Cargando…
Double Negative B Cell Is Associated With Renal Impairment in Systemic Lupus Erythematosus and Acts as a Marker for Nephritis Remission
Objective: Recent studies on double negative B cells (DN B cells) suggested that they have potential pathogenic roles in systemic lupus erythematosus (SLE). This study aimed to determine the circulating DN B cells in SLE patients and analyzed the clinical significance of this cell subset. Methods: F...
Autores principales: | You, Xujie, Zhang, Ruijun, Shao, Miao, He, Jing, Chen, Jiali, Liu, Jiajia, Zhang, Xia, Liu, Xu, Jia, Rulin, Sun, Xiaolin, Li, Zhanguo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7155774/ https://www.ncbi.nlm.nih.gov/pubmed/32318574 http://dx.doi.org/10.3389/fmed.2020.00085 |
Ejemplares similares
-
Efficacy and safety of low-dose IL-2 in the treatment of systemic lupus erythematosus: a randomised, double-blind, placebo-controlled trial
por: He, Jing, et al.
Publicado: (2020) -
Dickkopf-1 Is a Biomarker for Systemic Lupus Erythematosus and Active Lupus Nephritis
por: Xue, Jing, et al.
Publicado: (2017) -
Aberrant B-Cell Activation in Systemic Lupus Erythematosus
por: Kang, Na, et al.
Publicado: (2022) -
Terbinafine Induced Lupus Erythematosus With Progression to Lupus Nephritis
por: Hindosh, Naif, et al.
Publicado: (2022) -
Belimumab for systemic lupus erythematosus – Focus on lupus nephritis
por: Plüß, Marlene, et al.
Publicado: (2022)